Membrane Oxygenators Market – By Type, By Application, By Age Group, By End Use – Global Forecast, 2025 to 2034

Membrane Oxygenators Market Size

The global membrane oxygenators market, valued at USD 132.1 million in 2024, is projected to grow at a CAGR of 2.2% from 2025 to 2034. The increasing prevalence of respiratory and cardiac disorders, including conditions like ARDS, cardiogenic shock, and myocarditis, drives the demand for advanced oxygenation systems, with membrane oxygenators being essential. Additionally, the growing geriatric population, more susceptible to these conditions, further boosts market growth. Technological advancements, such as hollow fiber membranes that improve gas exchange efficiency, also contribute to their expanding adoption in clinical settings.
 

Another driver is the growing utilization of extracorporeal membrane oxygenation (ECMO) therapy in critical care, particularly during emergencies like acute myocardial infarctions or post-transplant complications. The COVID-19 pandemic also highlighted the importance of membrane oxygenators in managing severe respiratory failure cases, significantly boosting market awareness and adoption.
 

Increased healthcare spending in developing nations, coupled with the expansion of advanced healthcare infrastructure, has further propelled market growth. Government initiatives to improve healthcare access and increasing training for ECMO deployment are also encouraging the use of membrane oxygenators.
 

Moreover, the development of portable and user-friendly systems is expanding the application of these devices in neonatal and pediatric care. With these innovations and an emphasis on improving patient outcomes, the membrane oxygenators industry is poised for substantial growth over the coming years.
 

Membrane oxygenators are medical devices used in extracorporeal life support to facilitate gas exchange by removing carbon dioxide and delivering oxygen to the blood. Utilizing advanced membrane technologies like hollow fibers or flat sheets, they are essential in managing respiratory and cardiac failures, especially during ECMO procedures and critical care interventions.  
 

Membrane Oxygenators Market Trends

The rising prevalence of cardiovascular diseases (CVDs) is a significant driver of the global membrane oxygenators industry. CVDs, including coronary artery disease, heart failure, and myocardial infarction, have become leading causes of mortality worldwide. According to the World Health Organization (WHO), an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths, with an increasing incidence in both developed and developing countries.
 

• This surge in CVD cases necessitates the adoption of advanced medical technologies, such as membrane oxygenators, to support patients requiring extracorporeal membrane oxygenation (ECMO) therapy. Membrane oxygenators play a crucial role in oxygenating blood and removing carbon dioxide during cardiac surgeries, organ transplants, and emergency interventions like cardiogenic shock, thereby improving patient survival and recovery.
   
• The growing demand for life-supporting interventions in cardiac care, especially during high-risk surgeries or in critical conditions such as acute myocardial infarction and post-transplant complications, further fuels market growth.
   
• Additionally, increasing healthcare investments and the expansion of advanced cardiac care infrastructure are facilitating wider access to these essential life-saving devices.
   

Membrane Oxygenators Market Analysis

Based on type, the market is bifurcated as hollow fiber membrane oxygenators and flat sheet membrane oxygenators. The hollow fiber membrane oxygenators segment is expected to drive business growth and expand at a CAGR of 2.6%, reaching over USD 100.6 million by 2034.
 

• The segment is set to drive market growth due to its superior efficiency and widespread use in critical care. Hollow fiber membranes enable enhanced gas exchange, while the compact design suits ECMO procedures in emergencies like ARDS and cardiogenic shock.  
   
• Additionally, technological advancements in hollow fiber membranes, such as improved biocompatibility and reduced blood trauma, enhance their performance and safety, further boosting demand. These oxygenators are particularly favored in neonatal and pediatric care due to their adaptability for smaller patients.
   
• Furthermore, the increasing adoption of ECMO therapy during the COVID-19 pandemic showcased the vital role of hollow fiber membrane oxygenators in managing severe respiratory failure, significantly raising their profile in critical care.
   

Based on application, the membrane oxygenators market is segmented as respiratory, cardiac, and extra corporeal cardiopulmonary resuscitation. The respiratory segment is expected to drive business growth and expand at a CAGR of 1.9%, reaching over USD 72.5 million by 2034.
 

• The segment is a key driver in the market, attributed to the rising prevalence of respiratory disorders and increasing adoption of extracorporeal membrane oxygenation (ECMO) therapy.
   
• Conditions such as acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and pneumonia are becoming more common globally due to factors like aging populations, air pollution, and smoking. For instance, the WHO 2024, currently 64 million people have COPD and 3 million people died of COPD. These conditions often lead to severe respiratory failure, necessitating the use of advanced oxygenation systems like membrane oxygenators.
   
• The COVID-19 pandemic has further highlighted the critical role of ECMO and membrane oxygenators in managing severe respiratory complications. Hospitals and healthcare facilities are increasingly adopting these devices to stabilize patients with critical respiratory insufficiency.
   

Based on age group, the market is segmented as adults, neonates, and pediatrics. The adults segment is expected to drive business growth and expand at a CAGR of 2.7%, reaching over USD 108.4 million by 2034.
 

• Adults, particularly those aged 50 and above, represent a substantial proportion of the global population suffering from respiratory and cardiovascular diseases. Conditions such as COPD, acute respiratory distress syndrome (ARDS), and cardiogenic shock are more prevalent in this demographic, necessitating the use of advanced extracorporeal life-support systems, including membrane oxygenators.
   
• Furthermore, the rising incidence of lifestyle-related disorders, such as hypertension, diabetes, and obesity, which are risk factors for cardiac and respiratory conditions, further drives demand for oxygenation devices in adults.
   
• Additionally, the aging population contributes significantly to this segment growth. The United Nations projected that by 2050, the number of individuals aged 65 years or above across the world will be twice the number of children under age 5 and almost equivalent to the number of children under 12 years, heightening the need for specialized life-support devices.
   

Based on end use, the membrane oxygenators market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 43.9% in 2024.
 

• Hospitals are primary centers for critical care and advanced medical interventions, making them essential users of membrane oxygenators. These devices are critical in managing life-threatening conditions such as ARDS, cardiogenic shock, and post-cardiac surgery complications. The increasing number of cardiovascular and respiratory disease cases globally has significantly boosted demand for extracorporeal membrane oxygenation (ECMO) procedures in hospitals, where membrane oxygenators play a vital role.
   
• Moreover, hospitals are equipped with specialized infrastructure and highly trained medical staff to perform complex procedures requiring membrane oxygenators. The integration of advanced ECMO systems in intensive care units (ICUs) enhances patient outcomes, further driving demand in this segment. The rising prevalence of high-risk surgeries, organ transplants, and neonatal care cases requiring oxygenation support contributes to the growth of the hospital segment. 
   

U.S. membrane oxygenators market accounted for USD 44.2 million in 2024 and is anticipated to grow at a CAGR of 1.4% between 2025 to 2034 period.
 

• The growing prevalence of respiratory and cardiovascular conditions like ARDS and cardiogenic shock, coupled with an aging U.S. population prone to chronic illnesses, is driving the demand for ECMO procedures where membrane oxygenators are essential.
   
• A well-established healthcare infrastructure, increasing ECMO centers, and technological advancements in portable and efficient oxygenators further enhance their adoption, especially in neonatal and pediatric care.
   

UK market is projected to grow remarkably in the coming years.
 

• The UK’s aging population and the high prevalence of heart and circulatory diseases, with over 7.6 million affected, drive the need for advanced extracorporeal life support systems.
   
• The country’s robust healthcare infrastructure and widespread adoption of ECMO systems, supported by government initiatives, enhance the availability of critical care technologies.
   
• Increasing investment in research and development, along with growing awareness of ECMO’s effectiveness in life-threatening situations, contributes to market expansion.
   

China holds a dominant position in the Asia Pacific membrane oxygenators market.
 

• China’s large population, aging demographics, and lifestyle risks like smoking and air pollution drive the demand for advanced medical solutions, including ECMO systems. Government initiatives like Healthy China 2030 support the integration of state-of-the-art medical technologies in critical care.
   
• China is emerging as a manufacturing hub for medical devices, offering cost-effective production of membrane oxygenators. Lower production costs enable competitive pricing in both domestic and international markets, boosted by government support for healthcare infrastructure.
   
• The rise in medical tourism in China increases demand for advanced medical devices, including membrane oxygenators, as hospitals cater to both local and international patients seeking high-quality, affordable healthcare.
   

Membrane Oxygenators Market Share

The global membrane oxygenators industry features a mix of established players and emerging manufacturers, competing in a dynamic landscape driven by innovation and demand for advanced extracorporeal life-support systems. Leading companies account for a significant market share due to their robust portfolios, strong distribution networks, and investments in research and development. Market share is further influenced by strategic initiatives such as product launches, collaborations, and geographic expansion. Local manufacturers are gaining traction in cost-sensitive regions by offering affordable, high-quality products.
 

Membrane Oxygenators Market Companies

Prominent players operating in the membrane oxygenators industry include:

• Abbott
• BRAILE
• chalice
• CytoSorbents
• EUROSETS
• Fresenius
• GETINGE
• LivaNova
• Medtronic
• MicroPort
• NIPRO
• PrecisionMedical
• RECTUS MEDICAl
• TERUMO
• XENIOS
   

Membrane Oxygenators Industry News:

• In May 2023, Inspira Technologies announced the development of the VORTX Blood Oxygenator, an advanced technology designed to optimize oxygen saturation and carbon dioxide removal in blood, enhancing patient outcomes in critical care. 
   
• In February 2022, Getinge expanded its portfolio by acquiring U.S. based Talis Clinical, a leading provider of high-acuity IT software solutions for critical care, including extracorporeal membrane oxygenation (ECMO). This acquisition aligns with Getinge's strategic goal to strengthen its position in the ECMO and perfusion digital solutions market, leveraging Talis Clinical expertise to broaden its offering in advanced critical care systems.
   

The membrane oxygenators market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Hollow fiber membrane oxygenators
• Flat sheet membrane oxygenators

Market, By Application

• Respiratory
  • Respiratory failure
  • Pulmonary embolism
  • Acute respiratory distress syndrome
  • Pneumonia
  • COVID-19
• Cardiac
  • Decompensated cardiomyopathy
  • Acute myocardial infarction
  • Cardiogenic shock
  • Post-transplant complications
  • Myocarditis
• Extra corporeal cardiopulmonary resuscitation

Market, By Age Group

• Adults
• Neonates
• Pediatrics

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE